,58, 59, 60, 61, 62, 63 Previous studies have also examined inhibitors of PI3K, AKT, and mTOR signaling in canine tumors, including hemangiosarcoma, lymphoma, mast cell tumor, melanoma, mammary gland tumor, and OS.20 This evidence concerns the gene AKT1 and mast cell neoplasm.